CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
ORi sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03488238
NCT03488238N/ACompleted
CompareCT.gov

Correlation of Changes in PaO2 and ORi in Adult Patients

Masimo Corporation·interventional·Posted Apr 4, 2018·Updated Sep 20, 2021

In Brief

A clinical study evaluating ORi sensor for Hyperoxia. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. This is a prospective, non-blinded, non-randomized study of the Oxygen Reserve Index (ORi) in a clinical setting. It is designed to evaluate the correlations with ORi and changes in PaO2 and the potential use of ORi as an early warning of impending arterial oxygen desaturation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperoxia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 4, 2018
Enrollment StartAug 1, 2018
Primary CompletionSep 19, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 8.2 years ago

Interventions

ORi sensordevice

Noninvasive pulse oximeter sensor that is placed on the finger for measurement of ORi